Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
INAYA Capital is a venture capital firm based in the United States, specializing in the MedTech sector. The firm partners with innovators to develop medical technologies that deliver clinical relevance and economic value. They focus on early-stage investments, primarily from Seed to Series B, with a disciplined approach to capital deployment.
INAYA Capital invests in the MedTech sector, targeting therapeutic areas with significant human burden. Their stage-agnostic investment strategy emphasizes early-stage companies, focusing on problem-solution alignment, defensible science, and a clear path to clinical validation. Typical investments range from Seed to Series B stages.
INAYA Capital has backed notable companies in the MedTech space, including Canary Medical, Angiotech, Shifamed LLC, and Nyra Medical. These companies have achieved significant milestones, with some being acquired by major firms like Johnson & Johnson, Boston Scientific, Abbott, and Covidien.
Submit your pitch through their form at inayacapital.com.
Yes, INAYA Capital often leads investment rounds, particularly in early-stage companies where they can provide strategic guidance and support.
INAYA Capital is open to follow-on investments, especially for companies that demonstrate strong growth potential and alignment with their investment thesis.
Specific details about the size of INAYA Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.